Where to inject cagrilintide: learn the standard subcutaneous sites—abdomen, thigh, and upper arm—plus rotation tips, safety notes, and clinical trial context.
Cagrilintide is injected subcutaneously, and the standard sites are the abdomen, the front of the thigh, and the back of the upper arm. These are the same three areas used for most peptide and GLP-1 injections because they hold a reliable layer of fat under the skin. Cagrilintide is not FDA-approved for human use in the United States; it is an investigational amylin analog that has been studied mainly in combination with semaglutide.
What Cagrilintide Is and How It Is Given
Cagrilintide is a long-acting amylin analog. In clinical trials it has been given once weekly as a subcutaneous shot, often alongside semaglutide in a combination known as CagriSema.
Because the drug is still experimental, there is no approved label, no approved dose, and no approved injection schedule. Most dosing information circulating online comes from trial protocols or from research chemical suppliers, not from a regulatory approval.
A cagrilintide injection goes into subcutaneous fat rather than muscle or a vein. An intramuscular shot would change how quickly the drug is absorbed and is not the route that has been studied.
The Three Standard Subcutaneous Injection Sites
All three sites work, but they differ in convenience, comfort, and how easy they are to rotate.
| Site | Why people choose it | Practical notes |
|---|---|---|
| Abdomen | Largest area and easiest to see and reach | Stay at least 2 inches away from the navel and avoid the belt line |
| Front of the thigh | Easy to reach while seated; good for self-injection | Use the outer top of the thigh, not the inner thigh |
| Back of the upper arm | Comfortable for some people | Usually needs a second person to inject accurately |
Absorption is broadly similar across these sites. Many clinicians still prefer the abdomen because it is the easiest area to rotate consistently.
How to Rotate Injection Sites Correctly
Rotating sites is the single most important habit for avoiding lumps, hardened fat, and sore spots.
- Move at least one inch from the last injection each time.
- Work in a pattern, such as clockwise around the abdomen, so you do not reuse the same spot.
- Keep a simple log or rotate on a fixed weekly schedule.
- Skip any area that is bruised, scarred, tender, or inflamed.
The same rotation rules apply to other injectables, which is why people searching for where to inject tirzepatide find nearly identical guidance.
Step-by-Step Injection Technique
- Wash your hands and set out supplies on a clean surface.
- Check the vial or pen, the intended dose, and the expiration date.
- Wipe the skin with an alcohol swab and let it dry completely.
- Pinch a fold of skin, or stretch the skin flat if you have more fat tissue.
- Insert the needle at 90 degrees for most sites; a 45-degree angle is sometimes used by thinner people.
- Inject slowly, then hold the needle in place for about 10 seconds before withdrawing.
- Do not rub the site, and dispose of the needle in a sharps container.
Guidance on where to inject aod 9604 and other subcutaneous peptides follows the same basic steps, because the technique is driven by the tissue layer rather than the specific drug.
Sites and Areas to Avoid
Some areas should never be used for a subcutaneous peptide injection:
- The navel itself and a 2-inch ring around it.
- Scars, stretch marks, moles, and tattoos.
- Bruised, swollen, or infected skin.
- Muscle tissue, since cagrilintide is not an intramuscular drug.
- Any site you cannot see clearly.
If a site stays sore, red, or hard for more than a few days, stop injecting there and speak with a healthcare professional.
How Cagrilintide Compares to Other Injectable Peptides
Most subcutaneous peptides share the same map of injection sites, even though their dosing schedules differ.
| Compound | Typical route | Common sites |
|---|---|---|
| Cagrilintide | Subcutaneous, once weekly in trials | Abdomen, thigh, upper arm |
| Semaglutide or tirzepatide | Subcutaneous, weekly | Abdomen, thigh, upper arm |
| CJC-1295 and ipamorelin | Subcutaneous, often daily | Abdomen, thigh |
| AOD 9604 | Subcutaneous, often daily | Abdomen, thigh |
People who look up cjc-1295/ipamorelin where to inject typically see the abdomen and thigh recommended, and the reasoning is the same as for cagrilintide: those areas hold a steady layer of subcutaneous fat.
Safety, Sourcing, and Legal Status
Cagrilintide is not approved by the FDA or any other major regulator for human use. It is not a prescription medicine you can pick up at a US pharmacy.
Because of that status, anyone asking where to buy cagrilintide is usually looking at research chemical suppliers. Those products are not manufactured to pharmaceutical standards and are not verified for sterility or potency by a regulator.
Side effects reported across the amylin and GLP-1 class include nausea, vomiting, diarrhea, and injection-site reactions. Combining an unapproved peptide with other medications adds risks that have not been studied.
When to Talk to a Healthcare Professional
Speak with a clinician before injecting any unapproved peptide, and seek care immediately if you notice severe nausea, persistent vomiting, signs of infection at an injection site, or an allergic reaction.
If you are enrolled in a clinical trial, follow the instructions from the study team rather than general online guidance. Trial protocols can specify exact injection sites, needle sizes, and timing that differ from what you read elsewhere.
Frequently Asked Questions
Where do you inject cagrilintide?
Cagrilintide is injected subcutaneously into the abdomen, the front of the thigh, or the back of the upper arm. These are the same sites used for other subcutaneous peptides and GLP-1 drugs. Stay at least two inches away from the navel and rotate to a new spot each time.
Is cagrilintide FDA-approved for human use?
No. Cagrilintide is not FDA-approved for human use in the United States, and it is not available as a prescription medicine. It remains an investigational amylin analog studied mainly in combination with semaglutide. Products sold online are typically research chemicals and are not made to pharmaceutical standards.
Can cagrilintide be injected into a muscle?
No. Cagrilintide is designed for subcutaneous injection into the fat layer just under the skin, not into muscle. Intramuscular injection would change how the drug is absorbed and has not been studied. If you hit muscle or see blood, withdraw and use a fresh site.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.